Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q38360854
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000156.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q38360854
|
024
|
|
|
‡a
0000-0003-0745-2504
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q38360854
|
100
|
0 |
|
‡a
Paul De Sousa
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Paul De Sousa
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Paul De Sousa
‡c
investigador
‡9
ast
|
400
|
0 |
|
‡a
Paul De Sousa
‡c
ricercatore
‡9
it
|
400
|
0 |
|
‡a
Paul De Sousa
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's 5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation
|
670
|
|
|
‡a
Author's A role for intracellular calcium downstream of G-protein signaling in undifferentiated human embryonic stem cell culture.
|
670
|
|
|
‡a
Author's A scalable label-free approach to separate human pluripotent cells from differentiated derivatives.
|
670
|
|
|
‡a
Author's A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells
|
670
|
|
|
‡a
Author's Analysis of variation in relative mRNA abundance for specific gene transcripts in single bovine oocytes and early embryos
|
670
|
|
|
‡a
Author's Balancing open source stem cell science with commercialization
|
670
|
|
|
‡a
Author's Biologically equivalent substitutive technology: what is needed to manufacture pluripotent stem cells for next-generation platforms for discovery and therapy
|
670
|
|
|
‡a
Author's Brain-derived neurotrophic factor is a regulator of human oocyte maturation and early embryo development.
|
670
|
|
|
‡a
Author's Brain-derived neurotrophic factor promotes bovine oocyte cytoplasmic competence for embryo development.
|
670
|
|
|
‡a
Author's Cardiac malformation in neonatal mice lacking connexin43.
|
670
|
|
|
‡a
Author's Clinically failed eggs as a source of normal human embryo stem cells
|
670
|
|
|
‡a
Author's Cloned mice derived from embryonic stem cell karyoplasts and activated cytoplasts prepared by induced enucleation
|
670
|
|
|
‡a
Author's Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy
|
670
|
|
|
‡a
Author's Datasets of genes coexpressed with FBN1 in mouse adipose tissue and during human adipogenesis
|
670
|
|
|
‡a
Author's Deletion of the alpha(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep
|
670
|
|
|
‡a
Author's Derivation of the clinical grade human embryonic stem cell line RCe016-A (RC-12).
|
670
|
|
|
‡a
Author's Derivation of the clinical grade human embryonic stem cell line RCe017-A (RC-13).
|
670
|
|
|
‡a
Author's Derivation of the clinical grade human embryonic stem cell line RCe018-A (RC-14).
|
670
|
|
|
‡a
Author's Derivation of the clinical grade human embryonic stem cell line RCe019-A (RC-15).
|
670
|
|
|
‡a
Author's Derivation of the clinical grade human embryonic stem cell line RCe020-a (RC-16).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe006-A (RC-2).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe007-A (RC-3).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe008-A (RC-4).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe009-A (RC-5).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe010-A (RC-6).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe011-A (RC-7).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe012-A (RC-8).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCe014-A (RC-10).
|
670
|
|
|
‡a
Author's Derivation of the human embryonic stem cell line RCM1.
|
670
|
|
|
‡a
Author's Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application
|
670
|
|
|
‡a
Author's Dielectrophoresis: a review of applications for stem cell research
|
670
|
|
|
‡a
Author's Dielectrophoresis based discrimination of human embryonic stem cells from differentiating derivatives
|
670
|
|
|
‡a
Author's EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines
|
670
|
|
|
‡a
Author's Effect of cell confluence on production of cloned mice using an inbred embryonic stem cell line.
|
670
|
|
|
‡a
Author's Effects of donor oocytes and culture conditions on development of cloned mice embryos
|
670
|
|
|
‡a
Author's Effects of superovulated heifer diet type and quantity on relative mRNA abundances and pyruvate metabolism in recovered embryos.
|
670
|
|
|
‡a
Author's Elasticity of human embryonic stem cells as determined by atomic force microscopy.
|
670
|
|
|
‡a
Author's Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions
|
670
|
|
|
‡a
Author's Germinal vesicle material is essential for nucleus remodeling after nuclear transfer.
|
670
|
|
|
‡a
Author's High-density polymer microarrays: identifying synthetic polymers that control human embryonic stem cell growth.
|
670
|
|
|
‡a
Author's Hot Start to European Pluripotent Stem Cell Banking
|
670
|
|
|
‡a
Author's Human cloning: can it be made safe?
|
670
|
|
|
‡a
Author's Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro.
|
670
|
|
|
‡a
Author's Human parthenogenetic embryo stem cells: appreciating what you have when you have it.
|
670
|
|
|
‡a
Author's Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes
|
670
|
|
|
‡a
Author's Improvement of an electrical activation protocol for porcine oocytes
|
670
|
|
|
‡a
Author's Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.
|
670
|
|
|
‡a
Author's Long term mesenchymal stem cell culture on a defined synthetic substrate with enzyme free passaging.
|
670
|
|
|
‡a
Author's Maintenance of pregnancy in pigs with limited viable embryos
|
670
|
|
|
‡a
Author's Monocrotophos in Gandaman village: India school lunch deaths and need for improved toxicity testing
|
670
|
|
|
‡a
Author's Neurotrophin signaling in oocyte survival and developmental competence: a paradigm for cellular toti-potency.
|
670
|
|
|
‡a
Author's Normal development of preimplantation mouse embryos deficient in gap junctional coupling
|
670
|
|
|
‡a
Author's Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State
|
670
|
|
|
‡a
Author's Optimising the therapeutic safety of human embryonic stem cells through the evolution of defined culture systems supporting their isolation
|
670
|
|
|
‡a
Author's Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles
|
670
|
|
|
‡a
Author's Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).
|
670
|
|
|
‡a
Author's Proliferative lifespan is conserved after nuclear transfer
|
670
|
|
|
‡a
Author's Quality Assessment and Production of Human Cells for Clinical Use
|
670
|
|
|
‡a
Author's Quality Assured Characterization of Stem Cells for Safety in Banking for Clinical Application
|
670
|
|
|
‡a
Author's Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience
|
670
|
|
|
‡a
Author's Red blood cells from pluripotent stem cells for use in transfusion
|
670
|
|
|
‡a
Author's Regulation of Na+,K(+)-ATPase alpha subunit gene expression during mouse preimplantation development.
|
670
|
|
|
‡a
Author's Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
|
670
|
|
|
‡a
Author's Reprogramming of fibroblast nuclei after transfer into bovine oocytes
|
670
|
|
|
‡a
Author's Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage
|
670
|
|
|
‡a
Author's Semi-quantitative immunohistochemical detection of 5-hydroxymethyl-cytosine reveals conservation of its tissue distribution between amphibians and mammals.
|
670
|
|
|
‡a
Author's Somatic cell nuclear transfer in the pig: control of pronuclear formation and integration with improved methods for activation and maintenance of pregnancy.
|
670
|
|
|
‡a
Author's Somatic cell nuclear transfer: recent progress and challenges
|
670
|
|
|
‡a
Author's Sufficiency of hypoxia-inducible 2-oxoglutarate dioxygenases to block chemical oxidative stress-induced differentiation of human embryonic stem cells
|
670
|
|
|
‡a
Author's The effect of cytochalasin D on protein synthesis in Xenopus laevis oocytes
|
670
|
|
|
‡a
Author's The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines
|
670
|
|
|
‡a
Author's The road to providing human embryo stem cells for therapeutic use: the UK experience.
|
670
|
|
|
‡a
Author's Thermoresponsive hydrogel maintains the mouse embryonic stem cell "naïve" pluripotency phenotype.
|
670
|
|
|
‡a
Author's Transient expression of translation initiation factor eIF-4C during the 2-cell stage of the preimplantation mouse embryo: identification by mRNA differential display and the role of DNA replication in zygotic gene activation
|
670
|
|
|
‡a
Author's Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines
|
670
|
|
|
‡a
Author's White matter tract and glial-associated changes in 5-hydroxymethylcytosine following chronic cerebral hypoperfusion
|
670
|
|
|
‡a
Author's ਕਲੀਨਿਕਲ ਗ੍ਰੇਡ ਮਨੁੱਖੀ ਭਰੂਣ ਸਟੈਮ ਸੈੱਲ ਲਾਈਨ RCe020-a (RC-16) ਦੀ ਉਤਪਤੀ।
|
909
|
|
|
‡a
(orcid) 0000000307452504
‡9
1
|
919
|
|
|
‡a
qualityassessmentandproductionofhumancellsforclinicaluse
‡A
Quality Assessment and Production of Human Cells for Clinical Use
‡9
1
|
919
|
|
|
‡a
proliferativelifespanisconservedafternucleartransfer
‡A
Proliferative lifespan is conserved after nuclear transfer
‡9
1
|
919
|
|
|
‡a
roleforintracellularcalciumdownstreamofgproteinsignalinginundifferentiatedhumanembryonicstemcellculture
‡A
A role for intracellular calcium downstream of G-protein signaling in undifferentiated human embryonic stem cell culture.
‡9
1
|
919
|
|
|
‡a
5azacytidineimprovestheosteogenicdifferentiationpotentialofagedhumanadiposederivedmesenchymalstemcellsbydnademethylation
‡A
5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation
‡9
1
|
919
|
|
|
‡a
scalablelabelfreeapproachtoseparatehumanpluripotentcellsfromdifferentiatedderivatives
‡A
A scalable label-free approach to separate human pluripotent cells from differentiated derivatives.
‡9
1
|
919
|
|
|
‡a
thermoresponsiveandchemicallydefinedhydrogelforlongtermcultureofhumanembryonicstemcells
‡A
A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells
‡9
1
|
919
|
|
|
‡a
analysisofvariationinrelativemrnaabundanceforspecificgenetranscriptsinsinglebovineoocytesandearlyembryos
‡A
Analysis of variation in relative mRNA abundance for specific gene transcripts in single bovine oocytes and early embryos
‡9
1
|
919
|
|
|
‡a
balancingopensourcestemcellsciencewithcommercialization
‡A
Balancing open source stem cell science with commercialization
‡9
1
|
919
|
|
|
‡a
biologicallyequivalentsubstitutivetechnologywhatisneededtomanufacturepluripotentstemcellsfornextgenerationplatformsfordiscoveryandtherapy
‡A
Biologically equivalent substitutive technology: what is needed to manufacture pluripotent stem cells for next-generation platforms for discovery and therapy
‡9
1
|
919
|
|
|
‡a
brainderivedneurotrophicfactorisaregulatorofhumanoocytematurationandearlyembryodevelopment
‡A
Brain-derived neurotrophic factor is a regulator of human oocyte maturation and early embryo development.
‡9
1
|
919
|
|
|
‡a
ਕਲਨਕਲਗਰਡਮਨਖਭਰਣਸਟਮਸਲਲਈਨrce020arc16ਦਉਤਪਤ
‡A
ਕਲੀਨਿਕਲ ਗ੍ਰੇਡ ਮਨੁੱਖੀ ਭਰੂਣ ਸਟੈਮ ਸੈੱਲ ਲਾਈਨ RCe020-a (RC-16) ਦੀ ਉਤਪਤੀ।
‡9
1
|
919
|
|
|
‡a
whitemattertractandglialassociatedchangesin5hydroxymethylcytosinefollowingchroniccerebralhypoperfusion
‡A
White matter tract and glial-associated changes in 5-hydroxymethylcytosine following chronic cerebral hypoperfusion
‡9
1
|
919
|
|
|
‡a
variationsinhumanizedanddefinedcultureconditionssupportingderivationofnewhumanembryonicstemcelllines
‡A
Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines
‡9
1
|
919
|
|
|
‡a
transientexpressionoftranslationinitiationfactoreif4cduringthe2cellstageofthepreimplantationmouseembryoidentificationbymrnadifferentialdisplayandtheroleofdnareplicationinzygoticgeneactivation
‡A
Transient expression of translation initiation factor eIF-4C during the 2-cell stage of the preimplantation mouse embryo: identification by mRNA differential display and the role of DNA replication in zygotic gene activation
‡9
1
|
919
|
|
|
‡a
thermoresponsivehydrogelmaintainsthemouseembryonicstemcellnaivepluripotencyphenotype
‡A
Thermoresponsive hydrogel maintains the mouse embryonic stem cell "naïve" pluripotency phenotype.
‡9
1
|
919
|
|
|
‡a
roadtoprovidinghumanembryostemcellsfortherapeuticusetheukexperience
‡A
The road to providing human embryo stem cells for therapeutic use: the UK experience.
‡9
1
|
919
|
|
|
‡a
molecularkaryotypeof25clinicalgradehumanembryonicstemcelllines
‡A
The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines
‡9
1
|
919
|
|
|
‡a
effectofcytochalasin500onproteinsynthesisinxenopuslaevisoocytes
‡A
The effect of cytochalasin D on protein synthesis in Xenopus laevis oocytes
‡9
1
|
919
|
|
|
‡a
brainderivedneurotrophicfactorpromotesbovineoocytecytoplasmiccompetenceforembryodevelopment
‡A
Brain-derived neurotrophic factor promotes bovine oocyte cytoplasmic competence for embryo development.
‡9
1
|
919
|
|
|
‡a
cardiacmalformationinneonatalmicelackingconnexin43
‡A
Cardiac malformation in neonatal mice lacking connexin43.
‡9
1
|
919
|
|
|
‡a
clinicallyfailedeggsasasourceofnormalhumanembryostemcells
‡A
Clinically failed eggs as a source of normal human embryo stem cells
‡9
1
|
919
|
|
|
‡a
clonedmicederivedfromembryonicstemcellkaryoplastsandactivatedcytoplastspreparedbyinducedenucleation
‡A
Cloned mice derived from embryonic stem cell karyoplasts and activated cytoplasts prepared by induced enucleation
‡9
1
|
919
|
|
|
‡a
cumulusgeneexpressionasapredictorofhumanoocytefertilisationembryodevelopmentandcompetencetoestablishapregnancy
‡A
Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy
‡9
1
|
919
|
|
|
‡a
datasetsofgenescoexpressedwithfbn1inmouseadiposetissueandduringhumanadipogenesis
‡A
Datasets of genes coexpressed with FBN1 in mouse adipose tissue and during human adipogenesis
‡9
1
|
919
|
|
|
‡a
deletionofthealpha13galactosyltransferaseggta1geneandtheprionproteinprpgeneinsheep
‡A
Deletion of the alpha(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep
‡9
1
|
919
|
|
|
‡a
derivationoftheclinicalgradehumanembryonicstemcelllinerce016arc12
‡A
Derivation of the clinical grade human embryonic stem cell line RCe016-A (RC-12).
‡9
1
|
919
|
|
|
‡a
derivationoftheclinicalgradehumanembryonicstemcelllinerce017arc13
‡A
Derivation of the clinical grade human embryonic stem cell line RCe017-A (RC-13).
‡9
1
|
919
|
|
|
‡a
derivationoftheclinicalgradehumanembryonicstemcelllinerce018arc14
‡A
Derivation of the clinical grade human embryonic stem cell line RCe018-A (RC-14).
‡9
1
|
919
|
|
|
‡a
derivationoftheclinicalgradehumanembryonicstemcelllinerce019arc15
‡A
Derivation of the clinical grade human embryonic stem cell line RCe019-A (RC-15).
‡9
1
|
919
|
|
|
‡a
derivationoftheclinicalgradehumanembryonicstemcelllinerce020arc16
‡A
Derivation of the clinical grade human embryonic stem cell line RCe020-a (RC-16).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce006arc2
‡A
Derivation of the human embryonic stem cell line RCe006-A (RC-2).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce007arc3
‡A
Derivation of the human embryonic stem cell line RCe007-A (RC-3).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce008arc4
‡A
Derivation of the human embryonic stem cell line RCe008-A (RC-4).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce009arc5
‡A
Derivation of the human embryonic stem cell line RCe009-A (RC-5).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce010arc6
‡A
Derivation of the human embryonic stem cell line RCe010-A (RC-6).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce011arc7
‡A
Derivation of the human embryonic stem cell line RCe011-A (RC-7).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce012arc8
‡A
Derivation of the human embryonic stem cell line RCe012-A (RC-8).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinerce014arc10
‡A
Derivation of the human embryonic stem cell line RCe014-A (RC-10).
‡9
1
|
919
|
|
|
‡a
derivationofthehumanembryonicstemcelllinercm1
‡A
Derivation of the human embryonic stem cell line RCM1.
‡9
1
|
919
|
|
|
‡a
developmentandproductionofgoodmanufacturingpracticegradehumanembryonicstemcelllinesassourcematerialforclinicalapplication
‡A
Development and production of good manufacturing practice grade human embryonic stem cell lines as source material for clinical application
‡9
1
|
919
|
|
|
‡a
dielectrophoresisareviewofapplicationsforstemcellresearch
‡A
Dielectrophoresis: a review of applications for stem cell research
‡9
1
|
919
|
|
|
‡a
dielectrophoresisbaseddiscriminationofhumanembryonicstemcellsfromdifferentiatingderivatives
‡A
Dielectrophoresis based discrimination of human embryonic stem cells from differentiating derivatives
‡9
1
|
919
|
|
|
‡a
ebiscbestpracticehowtoensureoptimalgenerationqualificationanddistributionofipsclines
‡A
EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines
‡9
1
|
919
|
|
|
‡a
effectofcellconfluenceonproductionofclonedmiceusinganinbredembryonicstemcellline
‡A
Effect of cell confluence on production of cloned mice using an inbred embryonic stem cell line.
‡9
1
|
919
|
|
|
‡a
effectsofdonoroocytesandcultureconditionsondevelopmentofclonedmiceembryos
‡A
Effects of donor oocytes and culture conditions on development of cloned mice embryos
‡9
1
|
919
|
|
|
‡a
effectsofsuperovulatedheiferdiettypeandquantityonrelativemrnaabundancesandpyruvatemetabolisminrecoveredembryos
‡A
Effects of superovulated heifer diet type and quantity on relative mRNA abundances and pyruvate metabolism in recovered embryos.
‡9
1
|
919
|
|
|
‡a
elasticityofhumanembryonicstemcellsasdeterminedbyatomicforcemicroscopy
‡A
Elasticity of human embryonic stem cells as determined by atomic force microscopy.
‡9
1
|
919
|
|
|
‡a
expressionoffbn1duringadipogenesisrelevancetothelipodystrophyphenotypeinmarfansyndromeandrelatedconditions
‡A
Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions
‡9
1
|
919
|
|
|
‡a
germinalvesiclematerialisessentialfornucleusremodelingafternucleartransfer
‡A
Germinal vesicle material is essential for nucleus remodeling after nuclear transfer.
‡9
1
|
919
|
|
|
‡a
highdensitypolymermicroarraysidentifyingsyntheticpolymersthatcontrolhumanembryonicstemcellgrowth
‡A
High-density polymer microarrays: identifying synthetic polymers that control human embryonic stem cell growth.
‡9
1
|
919
|
|
|
‡a
hotstarttoeuropeanpluripotentstemcellbanking
‡A
Hot Start to European Pluripotent Stem Cell Banking
‡9
1
|
919
|
|
|
‡a
humancloningcanitbemadesafe
‡A
Human cloning: can it be made safe?
‡9
1
|
919
|
|
|
‡a
humanembryonicstemcellsrapidlytakeupandthenclearexogenoushumanandanimalprionsinvitro
‡A
Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro.
‡9
1
|
919
|
|
|
‡a
humanparthenogeneticembryostemcellsappreciatingwhatyouhavewhenyouhaveit
‡A
Human parthenogenetic embryo stem cells: appreciating what you have when you have it.
‡9
1
|
919
|
|
|
‡a
humantonsilderivedfolliculardendriticlikecellsarerefractorytohumanprioninfectioninvitroandtrafficdiseaseassociatedprionproteintolysosomes
‡A
Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes
‡9
1
|
919
|
|
|
‡a
improvementofanelectricalactivationprotocolforporcineoocytes
‡A
Improvement of an electrical activation protocol for porcine oocytes
‡9
1
|
919
|
|
|
‡a
lineagespecificdistributionofhighlevelsofgenomic5hydroxymethylcytosineinmammaliandevelopment
‡A
Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.
‡9
1
|
919
|
|
|
‡a
longtermmesenchymalstemcellcultureonadefinedsyntheticsubstratewithenzymefreepassaging
‡A
Long term mesenchymal stem cell culture on a defined synthetic substrate with enzyme free passaging.
‡9
1
|
919
|
|
|
‡a
maintenanceofpregnancyinpigswithlimitedviableembryos
‡A
Maintenance of pregnancy in pigs with limited viable embryos
‡9
1
|
919
|
|
|
‡a
monocrotophosingandamanvillageindiaschoollunchdeathsandneedforimprovedtoxicitytesting
‡A
Monocrotophos in Gandaman village: India school lunch deaths and need for improved toxicity testing
‡9
1
|
919
|
|
|
‡a
neurotrophinsignalinginoocytesurvivalanddevelopmentalcompetenceaparadigmforcellulartotipotency
‡A
Neurotrophin signaling in oocyte survival and developmental competence: a paradigm for cellular toti-potency.
‡9
1
|
919
|
|
|
‡a
normaldevelopmentofpreimplantationmouseembryosdeficientingapjunctionalcoupling
‡A
Normal development of preimplantation mouse embryos deficient in gap junctional coupling
‡9
1
|
919
|
|
|
‡a
novelhumanembryonicstemcellregulatorsidentifiedbyconservedanddistinctcpgislandmethylationstate
‡A
Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State
‡9
1
|
919
|
|
|
‡a
optimisingthetherapeuticsafetyofhumanembryonicstemcellsthroughtheevolutionofdefinedculturesystemssupportingtheirisolation
‡A
Optimising the therapeutic safety of human embryonic stem cells through the evolution of defined culture systems supporting their isolation
‡9
1
|
919
|
|
|
‡a
paracrinesignallingeventsinembryonicstemcellrenewalmediatedbyaffinitytargetednanoparticles
‡A
Paracrine signalling events in embryonic stem cell renewal mediated by affinity targeted nanoparticles
‡9
1
|
919
|
|
|
‡a
pointstoconsiderinthedevelopmentofseedstocksofpluripotentstemcellsforclinicalapplicationsinternationalstemcellbankinginitiativeiscbi
‡A
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).
‡9
1
|
919
|
|
|
‡a
sufficiencyofhypoxiainducible2oxoglutaratedioxygenasestoblockchemicaloxidativestressinduceddifferentiationofhumanembryonicstemcells
‡A
Sufficiency of hypoxia-inducible 2-oxoglutarate dioxygenases to block chemical oxidative stress-induced differentiation of human embryonic stem cells
‡9
1
|
919
|
|
|
‡a
somaticcellnucleartransferrecentprogressandchallenges
‡A
Somatic cell nuclear transfer: recent progress and challenges
‡9
1
|
919
|
|
|
‡a
somaticcellnucleartransferinthepigcontrolofpronuclearformationandintegrationwithimprovedmethodsforactivationandmaintenanceofpregnancy
‡A
Somatic cell nuclear transfer in the pig: control of pronuclear formation and integration with improved methods for activation and maintenance of pregnancy.
‡9
1
|
919
|
|
|
‡a
semiquantitativeimmunohistochemicaldetectionof5hydroxymethylcytosinerevealsconservationofitstissuedistributionbetweenamphibiansandmammals
‡A
Semi-quantitative immunohistochemical detection of 5-hydroxymethyl-cytosine reveals conservation of its tissue distribution between amphibians and mammals.
‡9
1
|
919
|
|
|
‡a
screeningethnicallydiversehumanembryonicstemcellsidentifiesachromosome20minimalampliconconferringgrowthadvantage
‡A
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage
‡9
1
|
919
|
|
|
‡a
reprogrammingoffibroblastnucleiaftertransferintobovineoocytes
‡A
Reprogramming of fibroblast nuclei after transfer into bovine oocytes
‡9
1
|
919
|
|
|
‡a
renewedassessmentoftheriskofemergentadvancedcelltherapiestotransmitneuroproteinopathies
‡A
Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies
‡9
1
|
919
|
|
|
‡a
regulationofna+k+atpasealphasubunitgeneexpressionduringmousepreimplantationdevelopment
‡A
Regulation of Na+,K(+)-ATPase alpha subunit gene expression during mouse preimplantation development.
‡9
1
|
919
|
|
|
‡a
redbloodcellsfrompluripotentstemcellsforuseintransfusion
‡A
Red blood cells from pluripotent stem cells for use in transfusion
‡9
1
|
919
|
|
|
‡a
rapidestablishmentoftheeuropeanbankforinducedpluripotentstemcellsebiscthehotstartexperience
‡A
Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience
‡9
1
|
919
|
|
|
‡a
qualityassuredcharacterizationofstemcellsforsafetyinbankingforclinicalapplication
‡A
Quality Assured Characterization of Stem Cells for Safety in Banking for Clinical Application
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
PTBNP|180441
|
996
|
|
|
‡2
ISNI|0000000076857888
|
996
|
|
|
‡2
ISNI|0000000068493578
|
996
|
|
|
‡2
LC|n 98080020
|
996
|
|
|
‡2
ISNI|0000000024955347
|
996
|
|
|
‡2
PTBNP|1212032
|
996
|
|
|
‡2
PTBNP|1383660
|
996
|
|
|
‡2
CAOONL|ncf10686487
|
996
|
|
|
‡2
ISNI|0000000035233817
|
996
|
|
|
‡2
ISNI|0000000046222187
|
996
|
|
|
‡2
BLBNB|000439296
|
996
|
|
|
‡2
LC|n 2009212715
|
996
|
|
|
‡2
LC|n 85055296
|
996
|
|
|
‡2
ISNI|0000000118701137
|
996
|
|
|
‡2
PTBNP|808344
|
996
|
|
|
‡2
BLBNB|000448613
|
996
|
|
|
‡2
BLBNB|001585248
|
996
|
|
|
‡2
LC|n 89657316
|
996
|
|
|
‡2
LC|n 2010203704
|
996
|
|
|
‡2
ISNI|0000000069510544
|
996
|
|
|
‡2
DNB|1053375948
|
996
|
|
|
‡2
DNB|1056247258
|
996
|
|
|
‡2
LC|n 2008054912
|
996
|
|
|
‡2
ISNI|0000000070229362
|
996
|
|
|
‡2
PLWABN|9811781437105606
|
996
|
|
|
‡2
ISNI|0000000069196559
|
996
|
|
|
‡2
PTBNP|1324128
|
996
|
|
|
‡2
ISNI|0000000067160253
|
996
|
|
|
‡2
ISNI|0000000139477904
|
996
|
|
|
‡2
BLBNB|000156557
|
996
|
|
|
‡2
SUDOC|277083540
|
996
|
|
|
‡2
BLBNB|001498054
|
996
|
|
|
‡2
LC|no2024005355
|
996
|
|
|
‡2
LC|n 81049746
|
996
|
|
|
‡2
ISNI|0000000074376992
|
996
|
|
|
‡2
CAOONL|ncf10498731
|
996
|
|
|
‡2
ISNI|0000000425116325
|
996
|
|
|
‡2
ISNI|0000000044437459
|
996
|
|
|
‡2
PTBNP|102520
|
996
|
|
|
‡2
NII|DA17167634
|
996
|
|
|
‡2
PTBNP|1160552
|
996
|
|
|
‡2
ISNI|0000000068589297
|
996
|
|
|
‡2
ISNI|0000000068782396
|
996
|
|
|
‡2
BNF|17066498
|
996
|
|
|
‡2
NUKAT|n 2018149676
|
996
|
|
|
‡2
LC|no2004090798
|
996
|
|
|
‡2
ISNI|0000000069325744
|
996
|
|
|
‡2
NKC|jo20221145574
|
996
|
|
|
‡2
ISNI|0000000373935184
|
996
|
|
|
‡2
LC|n 2010201059
|
996
|
|
|
‡2
PTBNP|1018368
|
996
|
|
|
‡2
BLBNB|000487699
|
996
|
|
|
‡2
BNF|16933508
|
996
|
|
|
‡2
LC|n 2011214568
|
996
|
|
|
‡2
LC|nr2003007582
|
996
|
|
|
‡2
PTBNP|1755256
|
996
|
|
|
‡2
ISNI|0000000432826528
|
996
|
|
|
‡2
BNC|981058509516506706
|
996
|
|
|
‡2
ISNI|0000000070939671
|
996
|
|
|
‡2
PTBNP|1584549
|
996
|
|
|
‡2
ISNI|0000000070330268
|
996
|
|
|
‡2
ISNI|0000000059005421
|
996
|
|
|
‡2
LC|no2006094623
|
996
|
|
|
‡2
LC|n 85328563
|
996
|
|
|
‡2
ISNI|0000000070303323
|
996
|
|
|
‡2
LC|n 2011205758
|
996
|
|
|
‡2
PTBNP|206213
|
996
|
|
|
‡2
ISNI|000000008477496X
|
996
|
|
|
‡2
PTBNP|1193494
|
996
|
|
|
‡2
ISNI|0000000070698038
|
996
|
|
|
‡2
PTBNP|948230
|
996
|
|
|
‡2
ISNI|0000000003114071
|
996
|
|
|
‡2
LC|n 2011007328
|
996
|
|
|
‡2
NII|DA11271112
|
996
|
|
|
‡2
PTBNP|1392077
|
996
|
|
|
‡2
SUDOC|119855410
|
996
|
|
|
‡2
BLBNB|000463662
|
996
|
|
|
‡2
LC|n 95922317
|
996
|
|
|
‡2
ISNI|0000000375648998
|
996
|
|
|
‡2
PTBNP|1022816
|
996
|
|
|
‡2
ISNI|000000049362062X
|
996
|
|
|
‡2
BNE|XX5609195
|
996
|
|
|
‡2
PTBNP|1089370
|
996
|
|
|
‡2
PTBNP|40964
|
996
|
|
|
‡2
PTBNP|1426860
|
996
|
|
|
‡2
LC|n 2022251886
|
996
|
|
|
‡2
DNB|1060668394
|
996
|
|
|
‡2
DNB|1026737699
|
996
|
|
|
‡2
ISNI|0000000068575338
|
996
|
|
|
‡2
PTBNP|1902661
|
996
|
|
|
‡2
PTBNP|1808598
|
996
|
|
|
‡2
SUDOC|192779974
|
996
|
|
|
‡2
ISNI|0000000436094029
|
996
|
|
|
‡2
ISNI|0000000070900099
|
996
|
|
|
‡2
ISNI|0000000108534419
|
996
|
|
|
‡2
BLBNB|000312321
|
996
|
|
|
‡2
BNF|14646772
|
996
|
|
|
‡2
ISNI|0000000069805481
|
996
|
|
|
‡2
ISNI|0000000024151242
|
996
|
|
|
‡2
LC|n 2012211452
|
996
|
|
|
‡2
ISNI|0000000069180880
|
996
|
|
|
‡2
PTBNP|1012600
|
996
|
|
|
‡2
LC|n 82013752
|
996
|
|
|
‡2
SUDOC|157568954
|
996
|
|
|
‡2
BLBNB|001524647
|
996
|
|
|
‡2
BIBSYS|98023973
|
996
|
|
|
‡2
PTBNP|1709616
|
996
|
|
|
‡2
LC|n 86077742
|
996
|
|
|
‡2
PLWABN|9812620261805606
|
996
|
|
|
‡2
PTBNP|84701
|
996
|
|
|
‡2
PTBNP|1532327
|
996
|
|
|
‡2
PTBNP|1110082
|
996
|
|
|
‡2
BNF|17898744
|
996
|
|
|
‡2
BLBNB|000360216
|
996
|
|
|
‡2
LC|n 88015237
|
996
|
|
|
‡2
PTBNP|1042771
|
996
|
|
|
‡2
BLBNB|001428318
|
996
|
|
|
‡2
LC|n 50010686
|
996
|
|
|
‡2
PTBNP|1740041
|
996
|
|
|
‡2
BAV|495_275985
|
996
|
|
|
‡2
ISNI|0000000078307564
|
996
|
|
|
‡2
LC|no 00007447
|
996
|
|
|
‡2
DNB|1193500273
|
996
|
|
|
‡2
J9U|987007376845605171
|
996
|
|
|
‡2
PTBNP|1106278
|
996
|
|
|
‡2
ISNI|0000000068900188
|
996
|
|
|
‡2
BLBNB|000553739
|
996
|
|
|
‡2
ISNI|0000000069931891
|
996
|
|
|
‡2
ISNI|0000000069383653
|
996
|
|
|
‡2
BLBNB|001603793
|
996
|
|
|
‡2
NII|DA17545028
|
996
|
|
|
‡2
LC|n 80130065
|
996
|
|
|
‡2
RERO|A016397762
|
996
|
|
|
‡2
ISNI|0000000076793992
|
996
|
|
|
‡2
DNB|139868135
|
996
|
|
|
‡2
SUDOC|150127197
|
996
|
|
|
‡2
PTBNP|1277463
|
996
|
|
|
‡2
SUDOC|180757261
|
996
|
|
|
‡2
BLBNB|000434373
|
996
|
|
|
‡2
ISNI|000000007072120X
|
996
|
|
|
‡2
ISNI|0000000025312191
|
996
|
|
|
‡2
ISNI|0000000035607954
|
996
|
|
|
‡2
SUDOC|174346654
|
996
|
|
|
‡2
SUDOC|250682419
|
996
|
|
|
‡2
ISNI|0000000027730469
|
996
|
|
|
‡2
J9U|987007413425905171
|
996
|
|
|
‡2
BLBNB|001018402
|
996
|
|
|
‡2
ISNI|0000000067677607
|
996
|
|
|
‡2
DNB|112461463X
|
996
|
|
|
‡2
ISNI|0000000114613746
|
996
|
|
|
‡2
PTBNP|91632
|
996
|
|
|
‡2
BLBNB|000296254
|
996
|
|
|
‡2
PTBNP|1376064
|
996
|
|
|
‡2
PTBNP|242008
|
996
|
|
|
‡2
PTBNP|1012433
|
996
|
|
|
‡2
ISNI|0000000068982312
|
996
|
|
|
‡2
LC|n 98058758
|
996
|
|
|
‡2
LC|n 2006218592
|
996
|
|
|
‡2
CAOONL|ncf10359699
|
996
|
|
|
‡2
ISNI|0000000077270704
|
996
|
|
|
‡2
DE633|pe30023514
|
996
|
|
|
‡2
BLBNB|001599368
|
996
|
|
|
‡2
ISNI|0000000112717365
|
996
|
|
|
‡2
BLBNB|000360219
|
996
|
|
|
‡2
LC|n 2005178360
|
996
|
|
|
‡2
ISNI|0000000072688116
|
996
|
|
|
‡2
BLBNB|000365942
|
996
|
|
|
‡2
PTBNP|1366916
|
996
|
|
|
‡2
LC|no2001050080
|
996
|
|
|
‡2
J9U|987010173747305171
|
996
|
|
|
‡2
ISNI|0000000111217246
|
996
|
|
|
‡2
SUDOC|267634188
|
996
|
|
|
‡2
ISNI|0000000118853667
|
996
|
|
|
‡2
DNB|1229838767
|
996
|
|
|
‡2
ISNI|0000000069787543
|
996
|
|
|
‡2
PTBNP|1299616
|
996
|
|
|
‡2
J9U|987007604885405171
|
996
|
|
|
‡2
LC|n 2010011175
|
996
|
|
|
‡2
LC|n 82019354
|
996
|
|
|
‡2
CAOONL|ncf11594404
|
996
|
|
|
‡2
LC|no2024101616
|
996
|
|
|
‡2
ISNI|0000000382429240
|
996
|
|
|
‡2
DNB|1057326747
|
996
|
|
|
‡2
PTBNP|1608402
|
996
|
|
|
‡2
DNB|1020259019
|
996
|
|
|
‡2
BNF|15534301
|
996
|
|
|
‡2
NTA|320817202
|
996
|
|
|
‡2
BLBNB|001128980
|
996
|
|
|
‡2
LC|no2009107683
|
996
|
|
|
‡2
BLBNB|000317633
|
996
|
|
|
‡2
BLBNB|000360221
|
996
|
|
|
‡2
ISNI|0000000114318448
|
996
|
|
|
‡2
PTBNP|1768190
|
996
|
|
|
‡2
SUDOC|231677766
|
996
|
|
|
‡2
PTBNP|1041066
|
996
|
|
|
‡2
BLBNB|000621796
|
996
|
|
|
‡2
ISNI|0000000115462118
|
996
|
|
|
‡2
ISNI|0000000070906765
|
996
|
|
|
‡2
J9U|987007331051205171
|
996
|
|
|
‡2
ISNI|0000000072631443
|
996
|
|
|
‡2
ISNI|0000000067568953
|
996
|
|
|
‡2
BNF|13547173
|
996
|
|
|
‡2
PTBNP|39061
|
996
|
|
|
‡2
BLBNB|000593577
|
996
|
|
|
‡2
PTBNP|972179
|
996
|
|
|
‡2
LC|n 2013201411
|
996
|
|
|
‡2
PTBNP|1428315
|
996
|
|
|
‡2
BNF|12138247
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|